Results 1,081-1,100 of 3,998 for speaker:Michael Harty

Written Answers — Department of Health: Health Services Staff Training (12 Mar 2019)

Michael Harty: 393. To ask the Minister for Health if there is a difference in the clinical performance between non-consultant hospital doctors trained here and internationally, respectively; and the way in which this is assessed and addressed. [12024/19]

Written Answers — Department of Health: Health Services Staff Data (12 Mar 2019)

Michael Harty: 394. To ask the Minister for Health if the dependency of Ireland on internationally trained non-consultant hospital doctors has grown or reduced between 2010 and 2018 and to date in 2019; and the reason therefor. [12025/19]

Written Answers — Department of Health: Health Services Data (12 Mar 2019)

Michael Harty: 395. To ask the Minister for Health when a unique identifier will be introduced for patients here; and the reason for the delay in the introduction of same. [12026/19]

Written Answers — Department of Health: Health Services Staff Data (12 Mar 2019)

Michael Harty: 402. To ask the Minister for Health the number of internationally trained non-consultant hospital doctors who were or are registered and working in hospitals here in each of the years 2016 to 2018 and to date in 2019, by hospital group. [12059/19]

Written Answers — Department of Agriculture, Food and the Marine: Plant Protection Products (12 Mar 2019)

Michael Harty: 482. To ask the Minister for Agriculture, Food and the Marine the impact on agriculture of the ban of a chemical (details supplied) introduced in France in January 2019; his plans to introduce a similar ban on the weedkiller here; and if he will make a statement on the matter. [11710/19]

Written Answers — Department of Communications, Climate Action and Environment: Electric Vehicles (12 Mar 2019)

Michael Harty: 549. To ask the Minister for Communications, Climate Action and Environment if the perceived inadequate number of ESB electric car charge points nationally will be recognised and remedied, in particular in County Clare (details supplied); and if he will make a statement on the matter. [12086/19]

Written Answers — Department of Transport, Tourism and Sport: Air Services Provision (12 Mar 2019)

Michael Harty: 563. To ask the Minister for Transport, Tourism and Sport the steps he is taking to assist Shannon Airport improve access after Brexit when its current hub, Heathrow Airport, will no longer be in the European Union; and if he will make a statement on the matter. [11685/19]

Written Answers — Department of Housing, Planning, and Local Government: Local Authority Housing Provision (12 Mar 2019)

Michael Harty: 697. To ask the Minister for Housing, Planning, and Local Government the reason Clare County Council has been informed that it can no longer purchase private dwellings for its social housing programme; the number of social houses or apartments built directly by the council that will be completed in 2019; and if he will make a statement on the matter. [11683/19]

Written Answers — Department of Housing, Planning, and Local Government: Home Loan Scheme (12 Mar 2019)

Michael Harty: 712. To ask the Minister for Housing, Planning, and Local Government the number of persons in County Clare assisted in buying their first home by availing of the Rebuilding Ireland home loan scheme; the number of applicants in County Clare who have been approved but have not drawn down the funding; and if he will make a statement on the matter. [12034/19]

Joint Oireachtas Committee on Health: Business of Joint Committee (6 Mar 2019)

Michael Harty: My apologies for starting the meeting late. I propose that the committee go into private session briefly to deal with some housekeeping matters.

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: The purpose of the meeting is to begin consideration of a national drugs policy. The committee has invited representatives from Access to Medicines Ireland to give their views on how the policy may be drawn up. Access to Medicines Ireland is a membership group composed of medical professionals, activists and concerned members of the public. The group is committed to ensuring that medicines...

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: I thank Dr. Harkin.

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: To open the discussion, the drug bill in Ireland is in the region of €2.3 billion a year. This committee has looked at the cost of drugs and came to the conclusion there are substantial savings to be made in respect of that bill. Before I open questions to other members, will our guests explain the nature of the compulsory licensing process?

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: Where does that operate?

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: I will go to our second round of speakers soon. From what I can gather from the contributions so far, the tension is between the pharmaceutical industry, a commercial entity driven by profit and responsible to shareholders, and health services with limited budgets, responsible to the populations and patients they serve. That is where the negotiations start. The EU Council has stated it is...

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: I presume countries would defend their right to decide what drugs are available and what price they pay but there must be a benefit in a common negotiating policy where one country is not played against another but that seems to be what is happening. Each country has a different price for the same drug, so it depends on what the market will bear.

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: Is there any movement in Europe that considers it from that moral perspective and decides that we should now have a united and common negotiating strategy, rather than each country adopting its own negotiating strategy, which seems to be a weakness?

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: The present model is not sustainable because the number of drugs that will come onto the market over the next five years for rare and ultra-rare diseases, and for new cancer treatments, will be so costly that no health system can afford to supply them all. We need to change our model for dealing with pharmaceutical companies because it will be unaffordable. What is the benefit compared with...

Joint Oireachtas Committee on Health: National Medicines Strategy: Discussion (6 Mar 2019)

Michael Harty: I thank Mr. Robbie Lawlor, Dr. Kieran Harkin and Dr. Ciara Conlan for their expert views on the pricing of medicine and the availability of medicines both in Ireland and abroad. We will have a number other meetings on this topic and we will produce a report, hopefully, which would inform Government on developing a national drugs policy. I propose that we adjourn the meeting until next...

Ceisteanna ó Cheannairí - Leaders' Questions (5 Mar 2019)

Michael Harty: The Taoiseach referred to his and my discipline of general practice in respect of Sláintecare. As he will know, the continuation of financial emergency measures in the public interest, FEMPI, has devastated general practice and it will take years for general practice to recover. He referred to the expansion of primary care, which is an essential component of Sláintecare, and he...